Helande
Helande Innovations, Inc.
Helande is developing Nervida to reduce the burden of repeat procedures for chronic back pain.
helande.co · San Diego, CA
Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$50K of $50K
Filed2026-11-06
Days since filing7
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2025-04-09
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Kabir GambhirExecutive Officer · Director
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$50K of $50K sold19.2 months since first sale
Prior raiseNot flaggedRaised $50K against a prior $70K$70K prior raise, filed 2026-11-05
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-11-110
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.